Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1988-10-19
pubmed:abstractText
In young infants who possess maternally derived respiratory syncytial virus (RSV) antibodies, the antibody response to RSV glycoproteins is relatively poor, despite extensive replication of RSV. In the present study, it was found that cotton rat RSV hyperimmune antiserum suppressed the antibody response to the RSV glycoproteins but not the response to vaccinia virus antigens when the antiserum was passively transferred to cotton rats prior to infection with vaccinia recombinant viruses expressing the RSV envelope glycoproteins. The cotton rats which had their immune responses suppressed by passively transferred antibodies were more susceptible to infection with RSV than were animals inoculated with control serum lacking RSV antibodies. Furthermore, many of the immunosuppressed animals infected with the vaccinia recombinant viruses developed RSV glycoprotein antibodies which had abnormally low neutralizing activities. Thus, preexisting serum RSV antibodies had dramatic quantitative and qualitative effects on the immune response to RSV glycoproteins, which may explain, in part, the poor RSV antibody response of young human infants to infection with RSV. Our observations also suggest that immunosuppression by preexisting, passively acquired RSV antibodies may constitute a major obstacle to RSV immunoprophylaxis during early infancy, when immunization is most needed.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
62
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3907-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:3047432-Animals, pubmed-meshheading:3047432-Antibodies, Viral, pubmed-meshheading:3047432-Antigens, Viral, pubmed-meshheading:3047432-Arvicolinae, pubmed-meshheading:3047432-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:3047432-Genetic Vectors, pubmed-meshheading:3047432-Glycoproteins, pubmed-meshheading:3047432-HN Protein, pubmed-meshheading:3047432-Humans, pubmed-meshheading:3047432-Immune Sera, pubmed-meshheading:3047432-Immune Tolerance, pubmed-meshheading:3047432-Immunization, Passive, pubmed-meshheading:3047432-Infant, pubmed-meshheading:3047432-Neutralization Tests, pubmed-meshheading:3047432-Respiratory Syncytial Viruses, pubmed-meshheading:3047432-Respirovirus Infections, pubmed-meshheading:3047432-Vaccinia virus, pubmed-meshheading:3047432-Viral Envelope Proteins, pubmed-meshheading:3047432-Viral Fusion Proteins, pubmed-meshheading:3047432-Viral Proteins
pubmed:year
1988
pubmed:articleTitle
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
pubmed:affiliation
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
pubmed:publicationType
Journal Article